Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

This study has been completed.
Information provided by (Responsible Party):
Teva Pharmaceutical Industries Identifier:
First received: October 28, 2003
Last updated: January 18, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)